Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Pathogenic and non-pathogenic Escherichia coli colonization and host inflammatory response in a defined microbiota mouse model.

Stromberg ZR, Van Goor A, Redweik GAJ, Brand MJW, Wannemuehler MJ, Mellata M.

Dis Model Mech. 2018 Sep 28. pii: dmm.035063. doi: 10.1242/dmm.035063. [Epub ahead of print]

2.

Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study).

Sarno G, Garg S, Onuma Y, Gutiérrez-Chico JL, van den Brand MJ, Rensing BJ, Morel MA, Serruys PW; ARTS-II Investigators.

Am J Cardiol. 2010 Nov 15;106(10):1369-75. doi: 10.1016/j.amjcard.2010.06.069. Epub 2010 Oct 1.

PMID:
21059423
3.

Cyphering the complexity of coronary artery disease using the syntax score to predict clinical outcome in patients with three-vessel lumen obstruction undergoing percutaneous coronary intervention.

Valgimigli M, Serruys PW, Tsuchida K, Vaina S, Morel MA, van den Brand MJ, Colombo A, Morice MC, Dawkins K, de Bruyne B, Kornowski R, de Servi S, Guagliumi G, Jukema JW, Mohr FW, Kappetein AP, Wittebols K, Stoll HP, Boersma E, Parrinello G; ARTS II.

Am J Cardiol. 2007 Apr 15;99(8):1072-81. Epub 2007 Mar 6.

PMID:
17437730
4.
5.

Soluble CD40 ligand in acute coronary syndromes.

Heeschen C, Dimmeler S, Hamm CW, van den Brand MJ, Boersma E, Zeiher AM, Simoons ML; CAPTURE Study Investigators.

N Engl J Med. 2003 Mar 20;348(12):1104-11.

6.

Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA.

Lenderink T, Boersma E, Heeschen C, Vahanian A, de Boer MJ, Umans V, van den Brand MJ, Hamm CW, Simoons ML; CAPTURE Investigators.

Eur Heart J. 2003 Jan;24(1):77-85.

PMID:
12559939
7.
8.

The effect of completeness of revascularization on event-free survival at one year in the ARTS trial.

van den Brand MJ, Rensing BJ, Morel MA, Foley DP, de Valk V, Breeman A, Suryapranata H, Haalebos MM, Wijns W, Wellens F, Balcon R, Magee P, Ribeiro E, Buffolo E, Unger F, Serruys PW.

J Am Coll Cardiol. 2002 Feb 20;39(4):559-64.

9.

Coronary restenosis elimination with a sirolimus eluting stent: first European human experience with 6-month angiographic and intravascular ultrasonic follow-up.

Rensing BJ, Vos J, Smits PC, Foley DP, van den Brand MJ, van der Giessen WJ, de Feijter PJ, Serruys PW.

Eur Heart J. 2001 Nov;22(22):2125-30.

PMID:
11686669
10.

Feelings of being disabled as a predictor of mortality in men 10 years after percutaneous coronary transluminal angioplasty.

van Domburg RT, Scmidt Pedersen S, van den Brand MJ, Erdman RA.

J Psychosom Res. 2001 Sep;51(3):469-77.

PMID:
11602216
11.

Long-term clinical outcome after coronary balloon angioplasty: identification of a population at low risk of recurrent events during 17 years of follow-up.

van Domburg RT, Foley DP, de Feyter PJ, van der Giessen W, van den Brand MJ, Serruys PW.

Eur Heart J. 2001 Jun;22(11):934-41.

PMID:
11428817
12.

Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease.

Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schönberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MA, van Hout BA; Arterial Revascularization Therapies Study Group.

N Engl J Med. 2001 Apr 12;344(15):1117-24.

13.

Completeness of revascularisation by percutaneous coronary intervention.

Breeman A, Boersma E, van den Brand MJ, van Herwerden L, Serruys PW.

Neth Heart J. 2001 Apr;9(1):3-9.

14.

The ARTS study (Arterial Revascularization Therapies Study).

Serruys PW, Unger F, van Hout BA, van den Brand MJ, van Herwerden LA, van Es GA, Bonnier JJ, Simon R, Cremer J, Colombo A, Santoli C, Vandormael M, Marshall PR, Madonna O, Firth BG, Breeman A, Morel MA, Hugenholtz PG.

Semin Interv Cardiol. 1999 Dec;4(4):209-19.

PMID:
10738354
15.

Corneal arcus: indicator for severity of coronary atherosclerosis?

Hoogerbrugge N, Happee C, van Domburg R, Poldermans D, van den Brand MJ.

Neth J Med. 1999 Oct;55(4):184-7.

PMID:
10555435
16.

Spontaneous dissections of all three coronary arteries in a 33-week-pregnant woman.

Rensing BJ, Kofflard M, van den Brand MJ, Foley DP.

Catheter Cardiovasc Interv. 1999 Oct;48(2):207-10.

PMID:
10506782
17.

Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the Glycoprotein Receptor Antagonist Patency Evaluation (GRAPE) pilot study.

van den Merkhof LF, Zijlstra F, Olsson H, Grip L, Veen G, Bär FW, van den Brand MJ, Simoons ML, Verheugt FW.

J Am Coll Cardiol. 1999 May;33(6):1528-32.

18.

[Abciximab: a new antiplatelet agent for use in coronary angioplasty].

van den Brand MJ, Simoons ML.

Ned Tijdschr Geneeskd. 1998 Dec 12;142(50):2728-32. Dutch.

PMID:
10065237
19.

Platelet glycoprotein IIB/IIIA receptor antagonists. An asset for treatment of unstable coronary syndromes and coronary intervention.

Ronner E, Dykun Y, van den Brand MJ, van der Wieken LR, Simoons ML.

Eur Heart J. 1998 Nov;19(11):1608-16. Review. No abstract available.

PMID:
9857912
20.

Women fare no worse than men 10 years after attempted coronary angioplasty.

Ruygrok PN, de Jaegere PP, van Domburg RT, van den Brand MJ, Serruys PW, de Feyter PJ.

Cathet Cardiovasc Diagn. 1996 Sep;39(1):9-15.

PMID:
8874938
21.

Long-term clinical outcome after stent implantation in saphenous vein grafts.

de Jaegere PP, van Domburg RT, Feyter PJ, Ruygrok PN, van der Giessen WJ, van den Brand MJ, Serruys PW.

J Am Coll Cardiol. 1996 Jul;28(1):89-96.

22.

Clinical outcome 10 years after attempted percutaneous transluminal coronary angioplasty in 856 patients.

Ruygrok PN, de Jaegere PT, van Domburg RT, van den Brand MJ, Serruys PW, de Feyter PJ.

J Am Coll Cardiol. 1996 Jun;27(7):1669-77.

23.

Antiplatelet therapy in therapy-resistant unstable angina. A pilot study with REO PRO (c7E3).

van den Brand MJ, Simoons ML, de Boer MJ, van Miltenburg A, van der Wieken LR, de Feyter PJ.

Eur Heart J. 1995 Nov;16 Suppl L:36-42.

PMID:
8869017
24.

Angiographic findings and catheterization laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction.

de Boer MJ, Reiber JH, Suryapranata H, van den Brand MJ, Hoorntje JC, Zijlstra F.

Eur Heart J. 1995 Oct;16(10):1347-55.

PMID:
8746902
25.

[Quality of life following coronary surgery and balloon angioplasty; more chest pain and social inhibition following angioplasty].

van Berkel TF, Erdman RA, Breeman A, Boersma H, van den Brand MJ.

Ned Tijdschr Geneeskd. 1995 Aug 26;139(34):1733-7. Dutch.

PMID:
7566240
26.
27.

Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous streptokinase in acute myocardial infarction.

de Boer MJ, Suryapranata H, Hoorntje JC, Reiffers S, Liem AL, Miedema K, Hermens WT, van den Brand MJ, Zijlstra F.

Circulation. 1994 Aug;90(2):753-61.

PMID:
8044944
28.

[Complications shortly after transluminal angioplasty or following coronary surgery in 183 comparable patients with multi-vessel coronary disease].

Breeman A, Serruys PW, van den Brand MJ, Deckers JW, van Herwerden LA, Roelandt JR.

Ned Tijdschr Geneeskd. 1994 May 21;138(21):1074-80. Review. Dutch.

PMID:
8202180
29.

Home measures of anxiety, avoidant coping and defence as predictors of anxiety, heart rate and skin conductance level just before invasive cardiovascular procedures.

de Jong M, Erdman RA, van den Brand MJ, Verhage F, Passchier J.

J Psychosom Res. 1994 May;38(4):315-22. Erratum in: J Psychosom Res 1994 Aug;38(6):637.

PMID:
8064649
30.

Randomized trial of a GPIIb/IIIa platelet receptor blocker in refractory unstable angina. European Cooperative Study Group.

Simoons ML, de Boer MJ, van den Brand MJ, van Miltenburg AJ, Hoorntje JC, Heyndrickx GR, van der Wieken LR, de Bono D, Rutsch W, Schaible TF, et al.

Circulation. 1994 Feb;89(2):596-603.

PMID:
7508826
31.

[Directional coronary atherectomy; initial Dutch experiences with a new percutaneous revascularization procedure].

Rensing BJ, Serruys PW, Laarman GJ, van den Brand MJ, Suryapranata H, de Feyter PJ.

Ned Tijdschr Geneeskd. 1990 May 12;134(19):962-7. Dutch.

PMID:
2348884
32.

[Incidence and results of re-interventions following coronary vessel surgery].

Laird-Meeter K, van Domburg R, van den Brand MJ, Lubsen J, Bos E, Hugenholtz PG.

Ned Tijdschr Geneeskd. 1988 Dec 17;132(51):2316-20. Dutch. No abstract available.

PMID:
2975355
33.

Incidence, risk, and outcome of reintervention after aortocoronary bypass surgery.

Laird-Meeter K, van Domburg R, van den Brand MJ, Lubsen J, Bos E, Hugenholtz PG.

Br Heart J. 1987 May;57(5):427-35.

34.

Angina pectoris, one to 10 years after aortocoronary bypass surgery.

Laird-Meeter K, ten Katen HJ, Brower RW, van den Brand MJ, Serruys PW, Haalebos MM, Bos E, Hugenholtz PG.

Eur Heart J. 1983 Oct;4(10):678-86.

PMID:
6606575
35.

Reoperation after aortocoronary bypass procedure. Results in 53 patients in a group of 1041 with consecutive first operations.

Laird-Meeter K, van den Brand MJ, Serruys PW, Penn OC, Haalebos MM, Bos E, Hugenholtz PG.

Br Heart J. 1983 Aug;50(2):157-62.

36.

[10 years of coronary surgery; results in 1041 patients operated on at the Thorax Center in Rotterdam].

Laird-Meeter K, ten Katen HJ, van Domburg R, van den Brand MJ, Serruys PW, Penn OC, Haalebos MM, Bos E, Hugenholtz PG.

Ned Tijdschr Geneeskd. 1983 Jun 4;127(23):988-94. Dutch. No abstract available.

PMID:
6603582
37.

Measurement of sodium in albumin solutions with ion-selective electrodes.

Mohan MS, Bates RG, Hiller JM, Brand MJ.

Clin Chem. 1978 Apr;24(4):580-4.

38.
39.
40.

Supplemental Content

Loading ...
Support Center